Antidote, the tech startup formerly known as TrialReach, is gearing up to introduce a tool to automatically match patients’ EHRs to clinical trials.
AOBiome is running an iPhone-enabled Phase IIb trial of its bacterial treatment for acne with Novartis ($NVS)-backed virtual trial CRO Science 37.
Researchers have found 110 antiviral targets and several existing drugs that may hit them using gene-trap insertional mutagenesis and a computational framework…
A consortium of cancer centers has contracted HudsonAlpha Institute of Biotechnology to sequence 20,000 samples by 2019.
Medidata has signed up to provide its cloud platform and mobile health capabilities to Techfields Pharma.
Quertle has introduced a platform to enable researchers to unearth relevant information from journal articles, patents and other documents.
A team at Stanford University School of Medicine has struck a liver cancer drug discovery deal with Andreessen Horowitz-backed twoXAR.
Medidata has teamed up with Shyft Analytics to use real-world evidence data to inform drug development strategies.
Sands Capital Ventures and Sequoia India have led precision oncology player Mitra Biotech to a $27.4 million Series B round.
Otsuka Pharmaceutical is looking to banish paper from clinical trials by working to prepare a 100% e-platform for use in Phase III.